Biomarkers van chronische ontstekingsziekten van de gewrichten.

Biomarkers in chronic inflammatory arthritic diseases.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29523

Enrollment

300

Registered

2011-03-31

Start date

2010-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

RA and SpA

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients 18 years or older with a diagnosis of chronic inflammatory arthritis e.g. rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, osteoarthritis, crystal arthropathy and undifferentiated arthritis, can be invited to participate in this study

Exclusion criteria

Exclusion criteria: Not able to give consent.

Design outcomes

Primary

Measure	Time frame
To identify novel biomarker reflexting cellular and molecular processes of the pathophysiology of chronic inflammatory arthritis, inclusie RA and SpA and to validate these biomarkers.	—

Secondary

Measure	Time frame
Generate a biobank with biological samples and clinical data in RA and SpA for the purpose of the development and validation of novel biomarkers.	—

Contacts

Public ContactP.P. Tak

Academic Medical Center (AMC), Department of Clinical Immunology and Rheumatology, P.O. Box 22660

p.p.tak@amc.nl+31 (0)20 5662171

Outcome results